Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_assertion type Assertion NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_head.
- NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_assertion description "[Altogether, the current generation of somatostatin analogs are effective medical tools in the treatment of acromegalic patients and of patients with neuroendocrine GEP tumors, but there is certainly a need for novel somatostatin analogs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_provenance.
- NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_assertion evidence source_evidence_literature NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_provenance.
- NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_assertion SIO_000772 16625843 NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_provenance.
- NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_assertion wasDerivedFrom befree-2016 NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_provenance.
- NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_assertion wasGeneratedBy ECO_0000203 NP545774.RA2uMFS7c3SpGkGFPaHHiLd5NKgMxVQ7nsZ3uycXNWSJg130_provenance.